FORWARD PHARMA A/S's ticker is FWP and the CUSIP is 34986J105. A total of 25 filers reported holding FORWARD PHARMA A/S in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $6,180,000 | -59.8% | 2,848,003 | -31.9% | 0.06% | -60.5% |
| Q4 2017 | $15,382,000 | -60.8% | 4,179,940 | -35.3% | 0.15% | -68.9% |
| Q3 2017 | $39,232,000 | -69.7% | 6,463,265 | +1.6% | 0.49% | -66.9% |
| Q2 2017 | $129,381,000 | +7.9% | 6,364,059 | +14.1% | 1.48% | +4.7% |
| Q1 2017 | $119,927,000 | +49.0% | 5,575,407 | +3.9% | 1.41% | +34.5% |
| Q4 2016 | $80,510,000 | -28.5% | 5,367,300 | 0.0% | 1.05% | -34.4% |
| Q3 2016 | $112,660,000 | +15.5% | 5,367,300 | 0.0% | 1.60% | +20.9% |
| Q2 2016 | $97,524,000 | +6.9% | 5,367,300 | 0.0% | 1.32% | +0.5% |
| Q1 2016 | $91,244,000 | -10.5% | 5,367,300 | 0.0% | 1.32% | -28.8% |
| Q4 2015 | $101,979,000 | -19.4% | 5,367,300 | 0.0% | 1.85% | -12.2% |
| Q3 2015 | $126,454,000 | -38.1% | 5,367,300 | 0.0% | 2.11% | -38.1% |
| Q2 2015 | $204,226,000 | +34.4% | 5,367,300 | 0.0% | 3.40% | +33.3% |
| Q1 2015 | $152,002,000 | +36.0% | 5,367,300 | 0.0% | 2.55% | +16.3% |
| Q4 2014 | $111,801,000 | – | 5,367,300 | – | 2.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,387,853 | $28,215,000 | 4.38% |
| SENZAR ASSET MANAGEMENT, LLC | 652,500 | $13,265,000 | 3.27% |
| Baupost Group | 6,364,059 | $129,381,000 | 1.48% |
| Assured Investment Management LLC | 1,511,043 | $26,982,000 | 0.56% |
| Perceptive Advisors | 194,718 | $3,959,000 | 0.20% |
| Rhenman & Partners Asset Management AB | 36,584 | $744,000 | 0.11% |
| DRW Securities, LLC | 17,000 | $346,000 | 0.06% |
| NJ State Employees Deferred Compensation Plan | 15,000 | $305,000 | 0.06% |
| Freedom Investment Management, Inc. | 20,178 | $410,000 | 0.02% |
| Acrospire Investment Management LLC | 942 | $19,000 | 0.02% |